Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4

PURPOSE: Asparaginase is a critical agent used to treat acute lymphoblastic leukemia (ALL). Pegaspargase (SS-PEG), a pegylated form of Escherichia coli L-asparaginase with a succinimidyl succinate (SS) linker, is the first-line asparaginase product used in Children's Oncology Group (COG) ALL tr...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Angiolillo, Anne L., Schore, Reuven J., Devidas, Meenakshi, Borowitz, Michael J., Carroll, Andrew J., Gastier-Foster, Julie M., Heerema, Nyla A., Keilani, Taha, Lane, Ashley R., Loh, Mignon L., Reaman, Gregory H., Adamson, Peter C., Wood, Brent, Wood, Charlotte, Zheng, Hao W., Raetz, Elizabeth A., Winick, Naomi J., Carroll, William L., Hunger, Stephen P.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2014
主題:
ORIGINAL REPORTS
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239306/
https://ncbi.nlm.nih.gov/pubmed/25348002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.5763
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料